We invest in novel science seeking breakthroughs that address critical unmet medical needs, have the potential to change the practice of medicine whilst generating attractive investor returns.
We are venture focused and make initial investments at levels from seed capital through early clinical development stages of truly innovative medicines and platform technologies. We have a long history of building high value, successful new companies developing transformational new medicines and bringing drugs from discovery to market.
SV can transform early science into leading companies and employ a company creation approach to biotech investing with many of these companies being created in house. We always welcome the opportunity to talk to entrepreneurs so please get in touch.